Froelichs Syndrome

Search Trials
Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
Status:
Recruiting
Last Changed:
Jan 13, 2022
First Changed:
Dec 7, 2021
Disease(s):
Hypothalamic Obesity
Intervention(s):
PlaceboTesomet
Phase 2b Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
Status:
Recruiting
Last Changed:
Dec 7, 2021
First Changed:
Dec 7, 2021
Disease(s):
Hypothalamic Obesity
Intervention(s):
PlaceboTesomet
International Rapid-onset Obesity With Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry
Status:
Recruiting
Last Changed:
Jun 25, 2021
First Changed:
May 1, 2017
Disease(s):
ROHHAD
Intervention(s):
ROHHAD
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
Status:
Completed
Last Changed:
Aug 21, 2020
First Changed:
Jan 27, 2016
Disease(s):
Hypothalamic Obesity
Intervention(s):
Exenatideplacebo
Impact of Metformin on Leptin Transport in Cerebrospinal Fluid of Obese Patients
Status:
Recruiting
Last Changed:
Feb 17, 2021
First Changed:
Jun 4, 2019
Disease(s):
Obesity Without Type 2 Diabetes, With BMI>30
Intervention(s):
Metformin Oral Tablet

Connect. Empower. Inspire.